BIOTESS SAW PALMETTO
Live / Applied — Response to non-final action entered (as of 26 Mar 2026)
What this means for you
Not registered yet, but its 27 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99618320
- Mark type
- Stylized text
- Filed
- 27 Jan 2026
Goods and services
- Class 005 — Pharmaceuticals: Dietary supplements and nutritional supplements containing saw palmetto; pharmaceutical preparation, namely, saw palmetto being a dietary supplement manufactured by a proprietary process that results in saw palmetto being absorbed in the intestinal tract in a time-dependent manner; pharmaceutical feature in the nature of a sustained-release delivery ingredient in the nature of dietary supplements and nutritional supplements, made in whole or significant part from saw palmetto, sold as an integral component of dietary supplements and nutritional supplements for increasing the level of saw palmetto for the purpose of improving urinary tract function, supporting prostate health, and stimulating hair growth.
Owner
- Tesseract Medical Research, LLC, Laguna Hills, CA, US
Prosecution history
- 26 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Feb 2026 — NON-FINAL ACTION E-MAILED
- 25 Feb 2026 — NON-FINAL ACTION WRITTEN
- 19 Feb 2026 — ASSIGNED TO EXAMINER
- 27 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 27 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Jan 2026 — NEW APPLICATION ENTERED